La Jolla Pharmaceutical Company
COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE

Last updated:

Abstract:

The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.

Status:
Application
Type:

Utility

Filling date:

30 Jul 2021

Issue date:

23 Jun 2022